Home
Search

Workforce Development, Diversity, & Inclusion at BIO

The Biotechnology Innovation Organization (BIO) is committed to creating a more globally competitive biotechnology industry by promoting and enhancing workforce development, diversity, and inclusion (WDDI). Our published principles inform our WDDI initiatives including the development of resources to foster an inclusive biotech industry.

BIO’s board-level WDDI Committee is chaired by Helen Torley, President & CEO of Halozyme.

WDDI Resources
WDDI Resources (3)
Diversity & Inclusion in the News
View All
Showing 1 - 2 of 2
Sep 12, 2019
Harvard Business Review
Research: When Women Are on Boards, Male CEOs Are Less Overconfident
GO TO SITE
FLIP
Sep 12, 2019
Harvard Business Review looks at whether female board representation could temper overconfidence in male CEOS which often leads to overestimating returns and underestimating risk.
GO TO SITE
FLIP
Jun 7, 2019
BioWorld
FDA issues draft guidance on enhancing diversity of trial participants
GO TO SITE
FLIP
Jun 7, 2019
With a major gap remaining between the demographics of people enrolled in clinical trials and those most likely to use the drugs the FDA approves, the agency issued a draft guidance.
GO TO SITE
FLIP
Videos
View All
Showing 1 of 1
Good Day BIO WDDI
Play
Jun 4, 2019
YouTube
Good Day BIO
FLIP
Jun 4, 2019
Helen Torley, Chair of BIO’s WDDI Committee and Joanne Duncan, BIO’s President, Membership and Business Operations Services on the set of Good Day BIO discussing the Right Mix Matters campaign.
PLAY VIDEO
FLIP